FIELD: medicine, pharmacology. SUBSTANCE: invention relates to the use of creatine phosphate and its pharmaceutically acceptable salts and pharmaceutical compositions based on thereof. Invention is useful for treatment of tumors exhibiting resistance to chemotherapeutic agents. EFFECT: enhanced effectiveness of treatment. 4 cl, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ADENOSINE DERIVATIVES, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION, AND METHOD OF PREPARING THEREOF | 1992 |
|
RU2129560C1 |
| TRIAZOLEPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO ANGIOTENSIN II RECEPTORS | 1992 |
|
RU2103270C1 |
| CHIMERIC POLYPEPTIDE SELECTIVELY REACTING WITH RELATED CHEMOKINE RECEPTOR, PHARMACEUTICAL COMPOSITION AND APPLICATION OF CHIMERIC POLYPEPTIDE (VERSIONS) | 2005 |
|
RU2430113C2 |
| MONOMETHYL AURISTATIN E CONJUGATE FOR PREPARING A COMPOSITION FOR TREATING PROSTATE CANCER | 2019 |
|
RU2729192C1 |
| USING 2-CHLOROETHYLPHOSPHONIC ACID AS ANTITUMOR AGENT | 2002 |
|
RU2309747C2 |
| METHOD FOR PREPARING MALONATEMETHYLIDINE NANOPARTICLES, NANOPARTICLES OPTIONALLY COMPRISING ONE OR SOME BIOLOGICALLY ACTIVE MOLECULES | 1997 |
|
RU2214421C2 |
| VIROSOMES CONTAINING HEMAGGLUTININ EXTRACTED FROM INFLUENZA VIRUS PRODUCED IN THE CELL LINES, COMPOSITIONS, CONTAINING SAID VIROSOMES, MEANS OF MANUFACTURING AND APPLICATIONS | 2008 |
|
RU2441647C2 |
| TRIAZOLOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2116308C1 |
| DRUG COMBINATION FOR GENE-IMMUNE THERAPY | 2022 |
|
RU2792683C1 |
| ERYTHROPOIETIN RELIEVES TOXICITY IN VIVO INDUCED BY CHEMOTHERAPY | 2002 |
|
RU2296563C2 |
